RHEUMATIC DISEASES AND TUBERCULOSIS INFECTION IN CHILDREN AND ADULTS
The authors summarized publications on the risk to develop tuberculosis during the treatment of rheumatic diseases with genetically engineered biologic drugs. The article describes the approaches to optimization of tuberculosis control activities in patients with rheumatic diseases: immunodiagnostic...
Gespeichert in:
Veröffentlicht in: | Tuberkulëz i bolezni lëgkikh 2019-03, Vol.97 (2), p.50-55 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The authors summarized publications on the risk to develop tuberculosis during the treatment of rheumatic diseases with genetically engineered biologic drugs. The article describes the approaches to optimization of tuberculosis control activities in patients with rheumatic diseases: immunodiagnostics of latent tuberculosis infection and prevention of tuberculosis disease in the patients receiving genetically engineered biological drugs. |
---|---|
ISSN: | 2075-1230 2542-1506 |
DOI: | 10.21292/2075-1230-2019-97-2-50-55 |